Supplementary Files
How to Cite
Abstract
Cartilage injuries remain a major challenge due to the avascular nature of cartilage and its limited regenerative capacity. Emerging evidence suggests that recent advances in mRNA-based therapeutics allow localized and transient expression of proteins relevant to cartilage repair. This literature review synthesizes current knowledge on mRNA delivery platforms, highlights key molecular targets such as SOX9 and FGF18 demonstrated in preclinical models, and summarizes emerging translational insights. While preclinical studies indicate meaningful potential for mRNA-based approaches in enhancing cartilage regeneration, substantial challenges—including delivery efficiency, stability within the joint environment, and regulatory complexity—must be addressed to ensure clinical applicability.
Keywords: Messenger RNA, Osteoarthritis, Lipid Nanoparticles, Regenerative Medicine, Drug Delivery Systems, Cytokines.
References
Li M, Yin H, Yan Z, Li H, Wu J, Wang Y et al. The immune microenvironment in cartilage injury and repair. Acta Biomater. 2022 Mar 1;140:23-42. https://doi.org/10.1016/j.actbio.2021.12.006
Skoracka J, Bajewska K, Kulawik M, Suchorska W, Kulcenty K. Advances in cartilage tissue regeneration: a review of stem cell therapies, tissue engineering, biomaterials, and clinical trials. EXCLI J. 2024;23:1170-1182. https://doi.org/10.17179/excli2024-7088
Fortier LM, Knapik DM, Dasari SP, Polce EM, Familiari F, Gursoy S,et Al. Clinical and Magnetic Resonance Imaging Outcomes After Microfracture Treatment With and Without Augmentation for Focal Chondral Lesions in the Knee: A Systematic Review and Meta-analysis. Am J Sports Med. 2023 Jul;51(8):2193-2206. https://doi.org/10.1177/03635465221087365
Migliorini F, Simeone F, Bardazzi T, Memminger MK, Pipino G, Vaishya R et al.Regenerative Cartilage Treatment for Focal Chondral Defects in the Knee: Focus on Marrow-Stimulating and Cell-Based Scaffold Approaches. Cells. 2025 Aug 7;14(15):1217. https://doi.org/10.3390/cells14151217
Goulian AJ, Goldstein B, Saad MA. Advancements in Regenerative Therapies for Orthopedics: a Comprehensive Review of Platelet-Rich Plasma, Mesenchymal Stem Cells, Peptide Therapies, and Biomimetic Applications. J. Clin. Med. 2025:14(6):2061. https://doi.org/10.3390/jcm14062061
Sahin U, Karikó K, Türeci Ö. mRNA-based Therapeutics — Developing a New Class of Drugs. Nat Rev Drug Discov, 2014 Oct;13(10):759-80.https://doi.org/10.1038/nrd4278
Pardi N, Hogan MJ, Weissman D. Recent Advances in mRNA Vaccine Technology. Curr Opin Immunol. 2020 Aug;65:14-20. https://doi.org/10.1016/j.coi.2020.01.008
Kowalski PS, Rudra A, Miao L, Anderson DG. Delivering the messenger: advances in technologies for therapeutic mRNA delivery. Molecular Therapy. 2019 Apr 10;27(4):710-28.https://doi.org/10.1016/j.ymthe.2019.02.012.
Qin S, Tang X, Chen Y, Chen K, Fan N, Xiao W et al.mRNA-based therapeutics: powerful and versatile tools to combat diseases. Signal Transduct Target Ther. 2022 May 21;7(1):166. https://doi.org/10.1038/s41392-022-01007-w
Neefjes M, Van Caam APM, Van der Kraan PM. Transcription Factors in Cartilage Homeostasis and Osteoarthritis. Biology (Basel). 2020 Sep 14;9(9):290.https://doi.org/10.3390/biology9090290
Zhang X, Li Y, Zhou Z. Lipid Nanoparticle-Based Delivery System─A Competing Place for mRNA Vaccines. ACS Omega. 2024 Jan 30;9(6):6219–34. https://doi.org/10.1021/acsomega.3c08353
Mancino C, Franke M, Greco A, Sontam T, Mcculloch P, Corbo C, et al. RNA therapies for musculoskeletal conditions. J Control Release.2025 Jan;377:756–66. https://doi.org/10.1016/j.jconrel.2024.11.057
Leng Q, Chen L, Lv Y. RNA-based scaffolds for bone regeneration: application and mechanisms of mRNA, miRNA and siRNA. Theranostics. 2020;10(7):3190–205. https://doi.org/10.7150/thno.42640
Chabanovska O, Galow AM, David R, Lemcke H. mRNA – A game changer in regenerative medicine, cell-based therapy and reprogramming strategies. Adv Drug Deliv Rev 2021 Dec;179:114002. https://doi.org/10.1016/j.addr.2021.114002
Karikó K, Muramatsu H, Welsh FA, Ludwig J, Kato H, Akira S, et al. Incorporation of Pseudouridine into mRNA Yields Superior Nonimmunogenic Vector with Increased Translational Capacity and Biological Stability. Molecular therapy : the journal of the American Society of Gene Therapy, 16(11), 1833–1840. https://doi.org/10.1038/mt.2008.200
Zhang NN, Li XF, Deng YQ, Zhao H, Huang YJ, Yang G, et al. A Thermostable mRNA Vaccine against COVID-19. Cell, 182(5), 1271–1283.e16. https://doi.org/10.1016/j.cell.2020.07.024
Chakraborty C, Sharma AR, Bhattacharya M, Lee SS. From COVID-19 to Cancer mRNA Vaccines: Moving from Bench to Clinic in the Vaccine Landscape. Front Immunol. 2021;12:679344. https://doi.org/10.3389/fimmu.2021.679344
Kulkarni JA, Cullis PR, van der Meel R. Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility. Nucleic Acid Ther. 2018;28(3):146-157. https://doi.org/10.1089/nat.2018.0721
Makarczyk MJ. Cell Therapy Approaches for Articular Cartilage Regeneration. Organogenesis. 2023 Dec 31;19(1):2278235. https://doi.org/10.1080/15476278.2023.2278235
Nieuwstraten J, Riester R, Hofmann UK, Guilak F, Danalache M. Matrix Metalloproteinases Accelerate Pericellular Matrix Breakdown and Disrupt Mechanotransduction in Osteoarthritis. Acta Biomater 2025 Feb 14;195:73–82.: https://doi.org/10.1016/j.actbio.2025.02.034.
Mandeda Madaiah P, Ghosh RN, Namboothiri PK, Peter M. Advancement in Scaffold-Based 3D Cell Culture Models for Osteosarcoma Drug Screening. ACS Biomater Sci Eng. 2025;11(11):6426-6442. https://doi.org/10.1021/acsbiomaterials.5c01174
Liu Y, Li W, Yang Z, Wei M, Yan L, Lv Y, et al. Peptide-Based Smart Nanosystem for Spatiotemporal Regulation of Bone Immunity and Cartilage Repair to Alleviate Osteoarthritis. Biomaterials. 2025 May 27;323:123440–0. https://doi.org/10.1016/j.biomaterials.2025.123440
Zhang Y, Zuo T, McVicar A, Yang HL, Li YP, Chen W. Runx1 Is a Key Regulator of Articular Cartilage Homeostasis by Orchestrating YAP, TGFβ, and Wnt Signaling in Articular Cartilage Formation and Osteoarthritis. Bone Res. 2022;10(1):63. https://doi.org/10.1038/s41413-022-00231-y
Shirvani H, Shamsoddini A, Bazgir B, McAinch AJ, Najjari A, Arabzadeh E. Metabolic crosstalk between skeletal muscle and cartilage tissue: insights into myokines in osteoarthritis. Mol Biol Rep. 2025 Dec;52(1):1-7. https://doi.org/10.1007/s11033-025-11072-3
Wang L, Chen X, Shi S, Yang X, Chen H, Xiao J. Advanced collagen-based Scaffolds for Cartilage and Osteochondral regeneration: a Review. Int J Biol Macromol. 2025 May 8;311:143992–2. https://doi.org/10.1016/j.ijbiomac.2025.143992
Shi S, Wang C, Acton AJ, Eckert GJ, Trippel SB. Role of Sox9 in Growth Factor Regulation of Articular Chondrocytes. J Cell Biochem. 2015 May 12;116(7):1391–400. https://doi.org/10.1002/jcb.25099
Rajderkar SS, Paraiso K, Amaral ML, Kosicki M, Cook LE, Darbellay F, Spurrell CH, Osterwalder M, Zhu Y, Wu H, Afzal SY. Dynamic enhancer landscapes in human craniofacial development. Nat Communications. 2024 Mar 6;15(1):2030. https://doi.org/10.1038/s41467-024-46396-4
Yano F, Shinsuke Ohba, Yasutaka Murahashi, Tanaka S, Saito T, Chung U. Runx1 Contributes to Articular Cartilage Maintenance by Enhancement of Cartilage Matrix Production and Suppression of Hypertrophic Differentiation. Sci Rep. 2019 May 21;9(1). https://doi.org/10.1038/s41598-019-43948-3
Fortier LA, Barker JU, Strauss EJ, McCarrel TM, Cole BJ. The Role of Growth Factors in Cartilage Repair .Clin Orthop Relat Res. 2011 Mar 15;469(10):2706–15. https://doi.org/10.1007/s11999-011-1857-3
Van Helvoort EM, van der Heijden E, van Roon JAG, Eijkelkamp N, Mastbergen SC. The Role of Interleukin-4 and Interleukin-10 in Osteoarthritic Joint Disease: a Systematic Narrative Review. Cartilage. 2022 Apr;13(2):194760352210981. https://doi.org/10.1177/19476035221098167
Lin CE, Crowley ST, Uchida S, Yuji Komaki, Kataoka K, Keiji Itaka. Treatment of Intervertebral Disk Disease by the Administration of mRNA Encoding a Cartilage-Anabolic Transcription Factor. Mol Ther Nucleic Acids. 2019 Jun 7;16:162–71. https://doi.org/10.1016/j.omtn.2019.02.012
Wen J, Li H, Dai H, Hua S, Long X, Li H, et al. Intra-articular nanoparticles based therapies for osteoarthritis and rheumatoid arthritis management. Mater Today Bio. 2023 Apr 1;19:100597. https:/doi:10.1016/j.mtbio.2023.100597
Li C, Du Y, Zhang T, Wang H, Hou Z, Zhang Y, et al. “Genetic scissors” CRISPR/Cas9 genome editing cutting-edge biocarrier technology for bone and cartilage repair. Bioact Mater. 2023 Apr 1;22:254-73. https://doi.org/10.1016/j.bioactmat.2022.09.026
Kong K, Li B, Chang Y, Zhao C, Qiao H, Jin M, et al. Delivery of FGF18 using mRNA-LNP protects the cartilage against degeneration via alleviating chondrocyte senescence. J Nanobiotechnology. 2025 Jan 22;23(1):34. https://doi.org/10.1186/s12951-025-03103-9
Aini H, Itaka K, Fujisawa A, Uchida H, Uchida S, Fukushima S, et al. Messenger RNA delivery of a cartilage-anabolic transcription factor as a disease-modifying strategy for osteoarthritis treatment. Sci Rep. 2016 Jan 5;6(1):18743. https://doi.org/10.1038/srep18743
Kong K, Li B, Chang Y, Zhao C, Qiao H, Jin M, et al. Delivery of FGF18 using mRNA-LNP protects the cartilage against degeneration via alleviating chondrocyte senescence. J Nanobiotechnology. 2025 Jan 22;23(1):34. https://doi.org/10.1186/s12951-025-03103-9
Zhou L, Ho KW, Zheng L, Xu J, Chen Z, Ye X, et al. A rabbit osteochondral defect (OCD) model for evaluation of tissue engineered implants on their biosafety and efficacy in osteochondral repair. Front Bioeng Biotechnol. 2024 May 3;12:1352023. https://doi.org/10.3389/fbioe.2024.1352023
Hamdalla HM, Ahmed RR, Galaly SR, Ahmed OM, Naguib IA, Alghamdi BS, et al . Assessment of the Efficacy of Bone Marrow‐Derived Mesenchymal Stem Cells against a Monoiodoacetate‐Induced Osteoarthritis Model in Wistar Rats. Stem Cells Int. 2022;2022(1):1900403. https://doi.org/10.1155/2022/1900403
Li X, Shen L, Deng Z, Huang Z. New treatment for osteoarthritis: Gene therapy. Precis Clin Med. 2023 Jun;6(2):pbad014. https://doi.org/10.1093/pcmedi/pbad014
Kong K, Li B, Chang Y, Zhao C, Qiao H, Jin M, et al. Delivery of FGF18 using mRNA-LNP protects the cartilage against degeneration via alleviating chondrocyte senescence. J Nanobiotechnology. 2025 Jan 22;23(1):34. https://doi.org/10.1186/s12951-025-03103-9
Chávez JC, McGrath M, Kearney CJ, Browne S, O’Brien FJ. Biomaterial scaffold-based gene delivery for the repair of complex wounds: Challenges, progress, and future perspectives. Cell Biomaterials. 2025 Apr 24. https://doi.org/10.1016/j.celbio.2025.100073
Shen J, Duan X, Xie T, Zhang X, Cai Y, Pan J, et al. Advances in locally administered nucleic acid therapeutics. Bioact Mater. 2025 Mar 10;49:218. https://doi.org/10.1016/j.bioactmat.2025.02.043
Winkler T, Oehme S, Hildebrandt A, Paolucci A, Pichler L. Evidence-based guidelines on orthobiologics. EFORT Open Reviews. 2025 Jun 1;10(6):345-51. https://doi.org/10.1530/EOR-2025-0069
Gomes Velasque Gama F, Casciani C, Dutra EH. FGF18 induces chondrogenesis and anti-osteoarthritic effects in a mouse model for TMJ degeneration. PloS One. 2025 Apr 24;20(4):e0317816. https://doi.org/10.1371/journal.pone.0317816
Song H, Park KH. Regulation and Function of SOX9 during Cartilage Development and Regeneration. Sem in Cancer Biol. 2020 Dec 1;67:12–23. https://doi.org/10.1016/j.semcancer.2020.04.008
Wee AS, Lim CK, Tan SL, Ahmad TS, Kamarul T. TGF-β1 and-β3 for mesenchymal stem cells chondrogenic differentiation on poly (vinyl alcohol)-chitosan-poly (ethylene glycol) scaffold. Tissue Eng Part C Methods. 2022 Oct 1;28(10):501-10. https://doi.org/10.1089/ten.tec.2022.0112
Zhou N, Li Q, Lin X, Hu N, Liao JY, Lin LB et al.BMP2 induces chondrogenic differentiation, osteogenic differentiation and endochondral ossification in stem cells. Cell Tissue Res. 2016 Oct;366(1):101-11. https://doi.org/10.1007/s00441-016-2403-0
Xian L, Wu X, Pang L, Lou M, Rosen CJ, Qiu T et al. Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells. Nat Med. 2012 Jul;18(7):1095-101.https://doi.org/10.1038/nm.2793
Zhao Y, Liu YS. Longevity Factor FOXO3: A Key Regulator in Aging-Related Vascular Diseases. Front Cardiovasc Med. 2021 Dec 23;8:778674. https://doi.org/10.3389/fcvm.2021.778674
Zhou C, Cui Y, Yang Y, Guo D, Zhang D, Fan Y, et al. Runx1 protects against the pathological progression of osteoarthritis. Bone Res. 2021 Dec 7;9(1):50. https://doi.org/ 10.1038/s41413-021-00173-x.
Wang M, Wang J, Xu X, Li E, Xu P. Engineering gene-activated bioprinted scaffolds for enhancing articular cartilage repair. Materials Today Bio. 2024 Dec 1;29:101351. https://doi.org/10.1016/j.mtbio.2024.101351
Liu L, Chen H, Zhao X, Han Q, Xu Y, Liu Y et al. Advances in the application and research of biomaterials in promoting bone repair and regeneration through immune modulation. Materials Today Bio. 2025 Feb 1;30:101410. https://doi.org/10.1016/j.mtbio.2024.101410
Gerstner M, Severmann AC, Chasan S, Vortkamp A, Richter W. Heparan sulfate deficiency in cartilage: enhanced BMP-sensitivity, proteoglycan production and an anti-apoptotic expression signature after loading. Int J Mol Sci. 2021 Apr 2;22(7):3726.https://doi.org/10.3390/ijms22073726
Kacprzak B, Stańczak M, Bielenda B, Yarmohammadi AA, Hagner-Derengowska M. Molecular Aspects of Cartilage Microfracturation: Rehabilitation Insights. Orthop Rev (Pavia).2025 Apr 22;17:129917. https://doi.org/10.52965/001c.129917
Chen S, Fu P, Cong R, Wu H, Pei M. Strategies to minimize hypertrophy in cartilage engineering and regeneration. Genes & diseases. 2015 Mar 1;2(1):76-95.https://doi.org/10.1016/j.gendis.2014.12.003
Hoshi H, Akagi R, Yamaguchi S, Muramatsu Y, Akatsu Y, Yamamoto Y, et al. Effect of inhibiting MMP13 and ADAMTS5 by intra-articular injection of small interfering RNA in a surgically induced osteoarthritis model of mice. Cell Tissue Res. 2017 May;368(2):379-387. https://doi.org/10.1007/s00441-016-2563-y
Jiang L, Lin J, Zhao S, Wu J, Jin Y, Yu L et al. ADAMTS5 in osteoarthritis: biological functions, regulatory network, and potential targeting therapies. Front. Mol. Biosci. 2021 Aug 9;8:703110. https://doi.org/10.3389/fmolb.2021.703110
Siebuhr AS, Werkmann D, Bay-Jensen AC, Thudium CS, Karsdal MA, Serruys B, Ladel C, Michaelis M, Lindemann S. The Anti-ADAMTS-5 Nanobody M6495 Protects Cartilage Degradation Ex Vivo. Int J Mol Sci. 2020 Aug 20;21(17):5992. https://doi.org/10.3390/ijms21175992
Van der Kraan PM. The interaction between joint inflammation and cartilage repair. TERM. 2019 Aug 14;16(4):327-34. https://doi.org/10.1007/s13770-019-00204-z
Ye L, Wen Z, Li Y, Chen B, Yu T, Liu L et al.Interleukin-10 attenuation of collagen-induced arthritis is associated with suppression of interleukin-17 and retinoid-related orphan receptor γt production in macrophages and repression of classically activated macrophages. Arthritis Res Ther. 2014 Apr 16;16(2):R96. https://doi.org/10.1186/ar4544
Clements AEB, Murphy WL. Injectable biomaterials for delivery of interleukin-1 receptor antagonist: Toward improving its therapeutic effect. Acta Biomater. 2019 Jul 15;93:123-134. https:// doi:10.1016/j.actbio.2019.04.051.
Yu HP, Liu FC, Chung YK, Alalaiwe A, Sung CT, Fang JY. Nucleic acid-based nanotherapeutics for treating sepsis and associated organ injuries. Theranostics. 2024 Jul 16;14(11):4411-4437. https://doi.org/10.7150/thno.98487
Wang X, Shi X, Wang R. Regulating mRNA endosomal escape through lipid rafts: A review. Int J Pharm. 2025 Apr 30;675:125571. https://doi.org/10.1016/j.ijpharm.2025.125571
Li J, Zhang H, Han Y, Hu Y, Geng Z, Su J. Targeted and responsive biomaterials in osteoarthritis. Theranostics. 2023 Jan 16;13(3):931-954. https://doi.org/10.7150/thno.78639
Wen J, Li H, Dai H, Hua S, Long X, Li H, et al. Intra-articular nanoparticles based therapies for osteoarthritis and rheumatoid arthritis management. Mater Today Bio. 2023 Feb 26;19:100597. https://doi.org/10.1016/j.mtbio.2023.100597
Shi Y, Mao J, Wang S, Ma S, Luo L, You J. Pharmaceutical strategies for optimized mRNA expression. Biomaterials. 2025 Mar;314:122853. https://doi.org/10.1016/j.biomaterials.2024.122853
Jiang XC, Zhang T, Gao JQ. The in vivo fate and targeting engineering of crossover vesicle-based gene delivery system. Adv Drug Deliv Rev. 2022 Aug;187:114324. https://doi.org/10.1016/j.addr.2022.114324
Pontes AP, Welting TJM, Rip J, Creemers LB. Polymeric Nanoparticles for Drug Delivery in Osteoarthritis. Pharmaceutics. 2022 Nov 29;14(12):2639. https://doi.org/10.3390/pharmaceutics14122639
Jiang XC, Zhang T, Gao JQ. The in vivo fate and targeting engineering of crossover vesicle-based gene delivery system. Adv Drug Deliv Rev. 2022 Aug;187:114324. https://doi.org/10.1016/j.addr.2022.114324.
Verbeke R, Hogan MJ, Loré K, Pardi N. Innate immune mechanisms of mRNA vaccines. Immunity.2022Nov8;55(11):1993-2005.https://doi.org/10.1016/j.immuni.2022.10.014.
Deshmukh R, Sethi P, Singh B, Shiekmydeen J, Salave S, Patel RJ, et al. Recent Review on Biological Barriers and Host–Material Interfaces in Precision Drug Delivery: Advancement in Biomaterial Engineering for Better Treatment Therapies. Pharmaceutics. 2024 .16(8):1076.https://doi.org/10.3390/pharmaceutics16081076
Watson-Levings, R. S., Palmer, G. D., Levings, P. P., Dacanay, E. A., Evans, C. H., & Ghivizzani, S. C. Gene Therapy in Orthopaedics: Progress and Challenges in Pre-Clinical Development and Translation. Front. Bioeng. Biotechnol, 2022.10, 901317. https://doi.org/ 10.3389/fbioe.2022.901317
DeJulius CR, Walton BL, Colazo JM, d’Arcy R, Francini N, Brunger JM, et al. Engineering approaches for RNA-based and cell-based osteoarthritis therapies. Nat. Rev. Rheumatol.2024 Jan 22;20(2):81–100. https://doi.org/ 10.1038/s41584-023-01067-4.
Nixon AJ, Haupt JL, Frisbie DD, Morisset SS, McIlwraith CW, Robbins PD, et al. Gene-mediated restoration of cartilage matrix by combination insulin-like growth factor-I/interleukin-1 receptor antagonist therapy. Gene Ther. 2004 Dec 2;12(2):177–86. https://doi.org/10.1038/sj.gt.3302396
Liu S, Deng Z, Chen K, Jian S, Zhou F, Yang Y, et al. Cartilage tissue engineering: From proinflammatory and anti-inflammatory cytokines to osteoarthritis treatments (Review). Mol. Med. Rep. 2022 Jan 24;25(3). https://doi.org/10.3892/mmr.2022.12615
Pickar-Oliver A, Gersbach CA. The next generation of CRISPR–Cas technologies and applications. Nat. Rev. Mol. Cell Biol. 2019 May 30;20(8):490–507.https://doi.org/ 10.1038/s41580-019-0131-5.
Uebelhoer M, Lambert C, Grisart J, Guse K, Plutizki S, Henrotin Y. Interleukins, growth factors, and transcription factors are key targets for gene therapy in osteoarthritis: A scoping review.Front.Med.2023Apr3;10.https://doi.org/ 10.3389/fmed.2023.1148623.
Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 2021 Dec;6(12):1078-94. https://doi.org/10.1038/s41578-021-00358-0
Balmayor ER. Synthetic mRNA–emerging new class of drug for tissue regeneration. Curr.Opin.Biotechnol.2022Apr1;74:8-14.https://doi.org/10.1016/j.copbio.2021.10.015
Kong K, Li B, Chang Y, Zhao C, Qiao H, Jin M, et al. Delivery of FGF18 using mRNA-LNP protects the cartilage against degeneration via alleviating chondrocyte senescence. J Nanobiotechnology. 2025 Jan 22;23(1):34. https://doi.org/ 10.1186/s12951-025-03103-9.
Deng J, Fukushima Y, Nozaki K, Nakanishi H, Yada E, Terai Y, et al. Anti-Inflammatory Therapy for Temporomandibular Joint Osteoarthritis Using mRNA Medicine Encoding Interleukin-1 Receptor Antagonist. Pharmaceutics. 2022 Aug 26;14(9):1785. https://doi.org/ 10.3390/pharmaceutics14091785.
Liu Y, Shah KM, Luo J. Strategies for articular cartilage repair and regeneration. Front. Bioeng. Biotechnol.2021Dec17;9:770655. https://doi.org/10.3389/fbioe.2021.770655
Du X, Nakanishi H, Yamada T, Sin Y, Minegishi K, Motohashi N et al. Polyplex Nanomicelle-Mediated Pgc-1α4 mRNA Delivery Via Hydrodynamic Limb Vein Injection Enhances Damage Resistance in Duchenne Muscular Dystrophy Mice. Adv Sci (Weinh). 2025 Apr;12(16):e2409065.https://doi.org/10.1002/advs.202409065
Thomas BL, Eldridge SE, Nosrati B, Alvarez M, Thorup AS, Nalesso G et al.WNT3A-loaded exosomes enable cartilage repair. J Extracell Vesicles. 2021 May;10(7):e12088. https://doi.org/ 10.1002/jev2.12088.
Baixing Li, Lei Cui, Keyu Kong, Yichuan Pang, Yan Chen, Shuning Zhang et al,LNP-mRNA delivers TNF-α antibody to deep cartilage and protects against osteoarthritis. Chem Eng. J, 2024:500,156723,https://doi.org/10.1016/j.cej.2024.156723.
Jallow MB, Huang K, Qiu M. Versatility of LNPs across different administration routes for targeted RNA delivery. J Mater Chem B. 2025;13:7637–7652. https://doi.org/10.1039/D5TB00575B
Terai Y, Yada E, Nakanishi H, Itaka K. mRNA-based combination therapy for inflammation-driven osteoarthritis induced by monosodium iodoacetate. Pharmaceutics.2025;17(10):1254.https://doi.org/10.3390/pharmaceutics17101254
Niazi SK. mRNA therapeutics beyond vaccines: dosing precision challenges and clinical translation framework. RSC Pharm. 2026. https://doi.org/10.1039/D5PM00159E.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright (c) 2026 Hafiz Muhammad Hamza, Shazaf Masood Sidhu , Naser Khan Ghafoor Jamal, Atiq Ur Rehman , Ghazanfar Ali Shah , Mehwish Riaz